LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Psychotropic Drug Makers Bankroll Prescribing Shrinks Part II
Sep-2-07 Washington, DC: Influence peddling in the field of psychiatry is out of control. An analysis of Minnesota disclosure records by the Pioneer Press and the consumer watchdog group Public Citizen shows that, between 2002 and 2006, 187 Minnesota doctors received payments from drug companies worth a grand total of $7.38 million. No other field of medicine ev... - Psychotropic Drug Makers Bankroll Prescribing Shrinks Part I
Aug-30-07 Washington, DC: On August 21, 2007, the Associated Press reported that drug companies spend a lot of money on the members of Minnesota advisory panels who help select the drugs which are to be used by patients covered by Medicaid. The news agency's review of financial disclosure records in Minnesota found that a doctor and a pharmacist on the 8-member p... - Ketek Scandal Shows Need for "Complete Overhaul" at FDA
Aug-25-07 Washington, DC Physicians and senate investigators are calling for a major overhaul in the drug regulation process at the US Food and Drug Administration, based on the recent scandal involving approvals for the antibiotic Ketek. Ketek has been linked to liver damage in dozens of cases, some of which resulted in liver failure and death. Earlier this ye... - American Kids Being Drugged To Death
Aug-22-07 Washington, DC: As result of the marketing power the pharmaceutical industry obtained by spending tens of billions of dollars to gain influence over politicians in power, the FDA and the medical profession, American kids are being pumped full of the most powerful and dangerous psychiatric medications on the market, in drug cocktails that are literally kill... - Avandia To Get Black Box Warning
Aug-19-07 Rockville, MD The U.S. Food and Drug Administration announced that Avandia , a controversial diabetes drug, will now carry a strong black box warning on its label. The new label will advise patients of the increased risk of heart failure associated with taking the drug. The warning label follows the release of studies that found using Avandia may incre... - Pollution Watchdog: Public Beach Pollution Worse in 2007
Aug-16-07 Buffalo, NY The Natural Resource Defense Council has published its annual list of the best--and worst--public beaches in the US, with findings that shoreline pollution has gotten worse. This pollution can make swimmers sick and lead to long-term problems for local residents and ecosystems. According to the NRDC report, this year storm water has washed... - More Scrutiny of Stenting for Profit Industry
Aug-13-07 Washington, DC: The stenting for profit industry hit a major snag on March 1, 2007, when the US House Oversight and Government Reform Committee, ordered Johnson & Johnson and Boston Scientific to turn over documents related to their sales and marketing activities for drug-eluting stents. Drug-eluting stents (DES) are mesh tubes used in patients with h... - Benzene a Known Carcinogenic
Aug-13-07 Fayettville, NC It might be in the contaminated soft drink you're gulping down on a hot day, in the water you're using to make coffee. It might be in the very air you breathe. Benzene is a known cancer-causing agent - and you'd be surprised to know just how prevalent the stuff really is. In fact, benzene ranks among the top 20 chemicals produced, and... - Avandia FDA Mole Hawks Lethal Medication Patches
Aug-12-07 Washington, DC: Douglas Arbesfeld, the pharmaceutical industry's mole inside the FDA, recently revealed his existence quite by accident when he attempted to destroy the reputation of cardiologist Dr. Steve Nissen by sending a malicious email to reporters after Dr. Nissen published a study that found the diabetes drug Avandia possibly increases the risk o... - Avandia Drug Maker Accused of Bullying Critics
Aug-9-07 Washington, DC An FDA Committee recently heard testimony from several scientists that suggests that early critics of the diabetes drug Avandia were intimidated by drug maker GlaxoSmithKline. Congressional investigators are examining what they call "very serious" claims that Glaxo "silenced one or more medical professionals who attempted to speak out... - Does New Warning For Ketek Go Far Enough?
Aug-8-07 Baltimore, MD At least four people have died and 37 others suffered liver damage after taking Ketek , an antibiotic made by Sanofi-Aventis. Now, many people are investigating the possibility of filing lawsuits after they suffered serious complications from taking the drug. The U.S. Food and Drug Administration (FDA) has responded by changing the labeling... - Avandia Allowed to Continue, Despite Risks
Jul-31-07 Gaithersburg, MD: Avandia , it seems, is back. In a remarkable turn of events, the diabetes drug that was vilified for cardiovascular risks only a few short months ago and made headlines around the world, was given a new lease on life by a federal drug advisory committee Monday. The vote to allow Avandia to remain on the market was described as 'overwh... - ReNu with MoistureLoc: Bausch & Lomb gets a Pass, but Hurdles Remain
Jul-30-07 Rochester, NY: In spite of its Greenville, South Carolina plant earning a pass after inspection by the FDA, Bausch & Lomb is still in the hot seat, facing more than 400 consumer lawsuits over its' recall last year of ReNu with MoistureLoc contact lens solution. The issue stems from a suspected link to Fusarium keratitus infection, which first surfaced... - CDC Leads SSRI Disinformation Media Blitz
Jul-20-07 Washington, DC: In a June 27, 2007 press release that made headlines all over the world the US Centers for Disease Control announced that birth defects associated with the use of antidepressants by pregnant women are rare. As proof for this claim, the CDC cited two new studies published in the New England Journal of Medicine. Over the following 2 week... - Ketek: Justifying the Risks
Jul-17-07 Bridgewater, NJ For some reason, the US Food and Drug Administration (FDA) felt that the benefits of using Ketek outweighed the risks, even though those risks include liver failure and possible death. The FDA approved the drug to treat mild sinus infections - infections that usually clear up on their own in a few days. Ketek was approved even though t... - FDA Internal Memo: Early "Black Box" Recommendation Ignored
Jul-14-07 Washington, DC A 2006 internal FDA memorandum suggests that the FDA recommended GlaxoSmithKline, the maker of Avandia , add a "black box" (the strongest warning) about congestive heart failure to the drug's label more than a year ago. As well, a warning about macular edema, which can lead to blindness, was also recommended. Even though the recommenda... - Trasylol Lawsuits Now Being Filed
Jul-14-07 Berkeley, CA As if patients facing heart bypass surgery did not already have enough to worry about, there is now a chance that Trasylol , a drug used to prevent blood loss, might actually increase their risk of kidney problems, heart attacks, and strokes. Patients who suffered serious injuries as a result of Trasylol are now filing lawsuits against the dr... - Big Pharma Implant For-Profit Industry Not Deserving of Preemption Protection Part I
Jul-9-07 Washington, DC: In addition to the question of how many soldiers will be dead or injured by the time self-proclaimed "war President" George Bush leaves office, Americans need to ask themselves how many citizens will be dead or injured as a result of an FDA controlled by the industry most credited with funding his move to the White House. Last year, the... - Scientists Demand Action on Avandia: New FDA Panels Formed
Jul-8-07 Cleveland, OH: At the recent American Diabetes Association's annual meeting in Chicago, Dr. Steven Nissen, chief of cardiology at the Cleveland Clinic, said early data on links between Avandia and cardiac events were ignored by the drug's maker, Glaxo Smith Klein, including findings presented at the FDA advisory meeting prior to Avandia's approval. "... - AMO Complete MoisturePlus: Link to Acanthamoeba Keratitis Confirmed
Jul-6-07 Jacksonville, FL: According to a just-released report, ongoing investigations have confirmed a strong link between AMO Complete MoisturePlus Multi-Purpose lens Solution , and increased risk for the development of Acanthamoeba keratitis (AK). In the July issue of the American Journal of Ophthalmology (AJO), researchers spoke of a "strong association" be...